The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hopman Mark since 2025.
This trader's CIK number is 2048497.
At the time of last reporting, Hopman Mark was the Chief Commercial Officer of Beta Bionics, Inc.. (stock ticker symbol BBNX).
Also see all insider trading activities at Beta Bionics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | BBNX | 0 | $0 | 17,874 | $299,964 | 16,158 | $82,405 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-02 | BBNX | Sale | 848 | 18.86 | 15,995 |
| 2025-08-19 | BBNX | Option Ex | 16,158 | 5.10 | 82,405 |
| 2025-08-19 | BBNX | Sale | 16,158 | 16.61 | 268,384 |
| 2025-06-02 | BBNX | Sale | 868 | 17.96 | 15,585 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hopman Mark (Chief Commercial Officer of Beta Bionics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.